Frequently Asked Questions
General FAQ
The Otsuka Patient Assistance Foundation, Inc (OPAF) is a nonprofit 501c(3) organization that provides free treatment to eligible uninsured and underinsured patients that have been prescribed:
- ABILIFY MAINTENA® (aripiprazole) extended-release injectable suspension
- JYNARQUE® (tolvaptan) tablets
- REXULTI® (brexpiprazole) tablets
- NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) capsules
- ABILIFY ASIMTUFII® (aripiprazole) extended-release injectable suspension
- VOYXACT® (sibeprenlimab-szsi) injection
See GLOBAL FULL PRESCRIBING INFORMATION for NUEDEXTA and VOYXACT.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
OPAF is funded by donations. Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.
Our mission is to inspire hope and make a meaningful, lasting impact for every individual we serve. We provide eligible people not only with free medications from Otsuka America Pharmaceutical Inc. and its US affiliated companies, but also care coordination services and wellness offerings.
Patient & Caregiver FAQ
Yes, you may submit an application by paper or online.
Patient & Prescribers, please use OPAF | Patient Forms to download the application forms.
Every patient is unique and has unique barriers that prevent them from accessing their medication. If you received a may NOT be eligible result from the eligibility tool, please call OPAF at 1-855-727-6274, Monday-Friday, 8am - 6pm ET and speak with one of our Patient Assistance Advocates to discuss your situation.
Yes. There are specific programs at OPAF that support patients that have been adversely impacted by a natural disaster. Please call OPAF at 1-855-727-6274, Monday-Friday, 8am - 6pm ET and speak with one of our Patient Assistance Advocates to discuss your situation.
There are many programs at OPAF that provide medication for different durations of time. A change in income or insurance status can affect the duration of time in our program, as well. However, our standard non-government issued enrollment, with no income or insurance changes, may provide free medication for a rolling 12 months from the date of approval. For patients that have government issued insurance such as Medicaid, Medicare, Medicare Part D their enrollment ends every year on December 31st per federal regulations.
When you submit an application, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:
- Federal Income Tax Return (1040, etc.)
- W-2 from previous tax year
- 1099-MISC form
- Two most recent paystubs
- Social Security award letter
- Disability income information
- Unemployment benefits letter
- Letter from employer on company letterhead
- Income attestation letter from healthcare prescriber
Eligibility is not determined by U.S. citizenship. However, a U.S. home address is required. Acceptable documentation includes one of the following:
- Mortgage statement or rental agreement
- Two (2) utility bills
- State driver’s license or State ID with current home address information
- U.S. address attestation letter from healthcare prescriber
OPAF performs a benefit verification for insured patients. If the benefit verification is insufficient, OPAF may require additional denial documentation such as:
- Explanation of benefits
- Insurance statement
- Prior authorization denial letter
A complete application is an application that is filled out in its entirety and has the required income and U.S. address documentation. Often, applications are submitted with missing information.
The most common missing information that we see from the enrollment forms is:
- Diagnosis Code (frequently it’s missing or off-label)
- Income/Household Size
- Often times, POI is provided that does not match the household size and there is no clarification (ex. HS is 3 but POI for only one person is provided). Or the application will state $0 income but we are missing the LOA from the HCP.
- We believe this piece of MI is starting to decrease a bit due to the recent income verification tool update relayed to the team.
- Ship To Box is not checked (Patient or Provider)
- Patient Consent Date
- This is often left blank or patients get confused and enter their DOB in the date section
Applications are denied after 90 days if information is not provided.
Please call OPAF at 1-855-727-6274, Monday-Friday, 8am - 6pm ET and speak with one of our Patient Assistance Advocates with any questions you have about the application process.
Once all the documentation and the application are submitted to OPAF, the application will go through an eligibility approval process. Once the application has completed the eligibility approval process, the OPAF team will notify you, as well as your HCP, what the application approval decision is.
If approved, the next steps are receiving your medication at no cost. OPAF will review the application to ensure that it is complete. If additional information is required, OPAF will contact your healthcare professional.
Once the application and all required documentation has been received ,you and your HCP will receive an answer within 5 business days. OPAF cannot process an application without all documentation. If there is missing information or documentation, the application may take longer to process and possibly denied after 90 days.
If you have any questions, please call our dedicated Patient Access Advocates. They can be reached at 1-855-727-6274, Monday-Friday, 8am - 6pm ET.
You may submit an application by paper or online.
Patients & Prescribers, please use OPAF | Patient Forms to download the application forms.
Your HCP may submit an application by paper or online.
Use OPAF | Patient Forms to download the application forms or use OPAF | Apply for your Patients to submit an application via the portal.
If you have any questions, please call our dedicated Patient Access Advocates. They can be reached at 1-855-727-6274, Monday-Friday, 8am - 6pm ET.
Healthcare Professionals FAQ
When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:
- Federal Income Tax Return (1040, etc.)
- W-2 from previous tax year
- 1099-MISC form
- Two most recent paystubs
- Social Security award letter
- Disability income information
- Unemployment benefits letter
- Letter from employer on company letterhead
- Income attestation letter from healthcare prescriber
Eligibility is not determined by U.S. citizenship. However, a U.S. home address is required. Acceptable documentation includes one of the following:
- Mortgage statement or rental agreement
- Two (2) utility bills
- State driver’s license or State ID with current home address information
- U.S. address attestation letter from healthcare prescriber
The application must also include insurance denial documentation. Acceptable documentation includes one of the following:
- Explanation of benefits
- Insurance statement
- Prior authorization denial letter
Patients that are enrolled with OPAF and have government-issued insurance such as Medicare, Medicare Part D, Medicaid are eligible for assistance up to December 31st of each calendar year. Patients that have non-government issued insurance or are uninsured are eligible to receive assistance for a rolling 12-month period. One month prior to their enrollment ending, a new application can be submitted for the following enrollment period.
If a patient is enrolled in OPAF’s temporary patient assistance program or natural disaster relief, they will receive free medication for 90 days with an option to reapply if needed.
Eversana Life Science Services is the distribution pharmacy for OPAF and is located at 17877 Chesterfield Airport Road, Chesterfield, MO 63005. Prescriptions may be faxed, mailed, e-prescribed or provided verbally to the pharmacy. If you have any questions, please contact Eversana Life Science Service by phone at 1-855-727-6274 or by FAX at 1-844-727-6274 during business hours: Monday-Friday, 8am - 6pm ET.
The medication shipment location is determined by the medication selected in the application and/or at the HCP’s discretion. Patients prescribed ABILIFY MAINTENA®(aripiprazole) extended-release injectable suspension or ABILIFY ASIMTUFII®(aripiprazole) extended-release injectable suspension must have the medication shipped to an HCP’s office or a local care center for administration.
NUEDEXTA®(dextromethorphan HBr and quinidine sulfate) capsules, REXULTI®(brexpiprazole) tablets, or VOYXACT® (sibeprenlimab-szsi) injections may be shipped to either the provider’s office or to the patient’s home.
See GLOBAL FULL PRESCRIBING INFORMATION for NUEDEXTA and VOYXACT.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
Yes, patients must have a diagnosis that is within the drug's approved indication(s) to qualify for no-cost medications from OPAF. This means patients who are being treated with Otsuka medications for conditions not indicated in the medication's approved Prescribing Information will not qualify for free treatment. Please contact a dedicated Patient Access Advocate by dialing 1-855-727-6274, Monday-Friday, 8am - 6pm ET if further clarification is needed.
Patients that have been prescribed ABILIFY MAINTENA® (aripiprazole) extended-release injectable suspension, ABILIFY ASIMTUFII®
(aripiprazole) extended-release injectable suspension, NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) capsules, JYNARQUE® (tolvaptan) tablets, and REXULTI® (brexpiprazole) tablets, may access the portal via OPAF Care Connect Patient Portal | Otsuka Patient Assistance Foundation.
Providers that have prescribed ABILIFY MAINTENA® (aripiprazole) extended-release injectable suspension, ABILIFY ASIMTUFII®
(aripiprazole) extended-release injectable suspension, NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) capsules and REXULTI® (brexpiprazole) tablets, may access the portal via OPAF Care Connect Prescriber Portal.
See GLOBAL FULL PRESCRIBING INFORMATION for NUEDEXTA and VOYXACT.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, and REXULTI.
If you need any additional help, please call OPAF at 1-855-727-6274, Monday-Friday, 8am - 6pm ET.